Anzeige
Mehr »
Montag, 25.08.2025 - Börsentäglich über 12.000 News
Mega-Deal in Kanada: Katapultiert sich diese Aktie jetzt in die Top-Liga der Explorer?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrBoehringer's Hernexeos granted FDA accelerated approval for lung cancer patients
FrFDA approves Celltrion's Actemra biosimilar Avtozma for cytokine release syndrome
FrWhy life cycle management is pharma's most underrated capability
DoDEBRA and Queen Mary partner to advance epidermolysis bullosa drug development
DoThe delicate balancing act of incorporating technology into healthcare
DoNHS programme to give head and neck cancer patients fast-track access to mRNA vaccine
DoFrom spark to surge: rethinking partnerships in healthcare communications
MiAbbVie/Genmab's lymphoma drug shows promise in phase 3 combination trial
MiFDA approves Jazz Pharmaceuticals' Modeyso as first drug for ultra-rare brain cancer
MiEmpathy is not a soft skill - it's a strategic one
DiSanofi's multiple myeloma candidate granted FDA orphan drug designation
DiJohnson & Johnson files FDA application for Tremfya in psoriatic arthritis
DiAre botanical drugs part of the future of medicine?
18.08.Gilead Sciences' Biktarvy granted FDA approval for expanded HIV use
18.08.FDA approves Apellis' Empaveli for two rare kidney diseases
18.08.Trust and trends - proactive protection
15.08.Eli Lilly's Alzheimer's drug Kisunla shows growing benefit in long-term study
15.08.BMS granted FDA priority review for Breyanzi in marginal zone lymphoma
15.08.Improving transparency and traceability within the supply chain's first mile
14.08.Ipsen receives EC approval for Cabometyx in advanced neuroendocrine tumours
14.08.FDA approves PTC Therapeutics' Sephience to treat rare metabolic disorder PKU
14.08.Motivating low-performance teams
13.08.GSK and Hengrui enter multi-programme collaboration agreement worth $12bn
13.08.AbbVie shares promising phase 3 results for Rinvoq in severe alopecia areata
13.08.Celebrating the Cannes Lions International Festival of Creativity